HIV-proteinase is essential for proteolytic processing of the viral gag and gag-pol precursor proteins for active HIV replication in infected cells. We have shown that cerulenin, a naturally occuring antibiotic in combination with zinc, significantly inhibited HIV replication in T-cells. We also synthesized several synthetic peptides derived from the C-terminal region of HIV-proteinase sequences, and tested their ability to inhibit HIV replication in peripheral blood T-cells. Out of four peptides, one hexapeptide with the amino acid sequence Ac-gly-cys-thr-leu-asn-phe-COOH, we named MURUGA, was found to have high antiviral activity. The effective delivery of these peptides into HIV-infected T-cells, which express CD4 on their surface, was accomplished by encapsulation of peptides into liposomes conjugated with anti-CD4 antibody.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BP003015-01
Application #
2456638
Study Section
Special Emphasis Panel (LIC)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Bureau of Health Planning and Resources Development
Department
Type
DUNS #
City
State
Country
United States
Zip Code